EUVIMEDEUVIMED entdecken
Crossref

Association Between Chronic Proton Pump Inhibitor Use and Hypomagnesemia Among Patients with Chronic Kidney Disease

Huma Andleeb Choudhary, Gohar Ali Khan, Aiman Tufail, Waseem Ahsen, Meshqat Ullah Khan, Shahid Ahmed

International Journal of Drug Delivery Technology · 04.04.2026 · 16 (88s)

DOI: 10.25258/ijddt.16.89s.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 04.04.2026. Verfasst von Huma Andleeb Choudhary und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Proton pump inhibitors (PPIs) are commonly used drugs which have the potential to impair intestinal magnesium absorption. Electrolyte disturbances may be especially problematic if someone has chronic kidney disease (CKD) and takes medications for a long time.

Objective

To determine the association between chronic PPI use and hypomagnesemia among patients with CKD.

Methods

A comparative analytical cross-sectional study was conducted at Government General Hospital, Samanabad, Faisalabad, from 1st February 2026 to 30th July 2026. A total of 120 patients with CKD were included, comprising 60 chronic PPI users and 60 non-users. Groups were compared for serum magnesium levels and hypomagnesemia was considered to be serum magnesium less than 1.7 mg/dL. Logistic regression analysis was employed to evaluate the relationship between PPI use and hypomagnesemia, adjusting for other potential confounders.

Results

PPI users had significantly lower mean serum magnesium levels than non-users (1.78 ± 0.29 mg/dL vs 1.93 ± 0.31 mg/dL, respectively, p=0.008). The prevalence of hypomagnesemia was higher in PPI users than non-users (p=0.049). The unadjusted odds ratio was 2.31 (p=0.049). The association was not statistically significant; however, after adjustment for potential confounders (p=0.079).

Conclusion

Chronic PPI use was associated with lower serum magnesium levels and a higher frequency of hypomagnesemia among patients with CKD, although the adjusted association was not statistically significant. Further studies with larger samples are needed to clarify this relationship. Keywords: Chronic kidney Disease, Proton Pump Inhibitors, Hypomagnesemia, Serum Magnesium, Electrolyte Disturbances.

Zitieren

APA

Choudhary, H. A., Khan, G. A., Tufail, A., Ahsen, W., Khan, M. U., & Ahmed, S. (2026). Association Between Chronic Proton Pump Inhibitor Use and Hypomagnesemia Among Patients with Chronic Kidney Disease. International Journal of Drug Delivery Technology, 16(88s). https://doi.org/10.25258/ijddt.16.89s.3

Vancouver

Choudhary HA, Khan GA, Tufail A, Ahsen W, Khan MU, Ahmed S. Association Between Chronic Proton Pump Inhibitor Use and Hypomagnesemia Among Patients with Chronic Kidney Disease. International Journal of Drug Delivery Technology. 2026;16(88s). doi:10.25258/ijddt.16.89s.3

BibTeX
@article{Choudhary2026,
  author = {Choudhary, Huma Andleeb and Khan, Gohar Ali and Tufail, Aiman and Ahsen, Waseem and Khan, Meshqat Ullah and Ahmed, Shahid},
  title = {Association Between Chronic Proton Pump Inhibitor Use and Hypomagnesemia Among Patients with Chronic Kidney Disease},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {88s},
  doi = {10.25258/ijddt.16.89s.3}
}
Kostenlos starten →